Is Summit Therapeutics Inc (NASDAQ: SMMT) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

SMMT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $4.62 and fluctuated between $5.0000 as its day high and $4.5650 as its day low. The current market capitalization of Summit Therapeutics Inc is $3.24B. A total of 9.74 million shares were traded on the day, compared to an average of 2.02M shares.

In the most recent transaction, Dhingra Ankur bought 20,400 shares of SMMT for 2.17 per share on Dec 13 ’23. After the transaction, the Chief Financial Officer now owns 254,958 company shares. In a previous transaction on Dec 12 ’23, Zanganeh Mahkam bought 5,000 shares at 2.07 per share. SMMT shares that Chief Executive Officer owns now total 494,814.

Among the insiders who bought shares, Soni Manmeet Singh acquired of 2,976,190 shares on Oct 13 ’23 at a per-share price of $1.68. This resulted in the Chief Operating Officer holding 2,976,190 shares of SMMT after the transaction.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SMMT has a high of $5.22 and a low of $1.30.

As of this writing, SMMT has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.11, while its Total Shareholder’s Equity was $83.28M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 0.00.

Most Popular

Related Posts